The Costco egg recall has been raised to a class 1 alert by the U.S. Food and Drug Administration over Salmonella concerns.

There were approximately 10,800 retail units of the affected eggs sold at 25 Costco stores in five states beginning on Nov. 22.

The FDA has updated the Costco egg recall to class I, meaning there's a "reasonable probability" that eating the eggs will "cause serious adverse health consequences or death."

The Food and Drug Administration has escalated its warning regarding certain eggs distributed to Costco locations, potentially linked to salmonella exposure.

Federal food regulators raised their alarm for recalled eggs sold from Costco stores over possible salmonella exposure, reclassifying the targeted product to its highest risk level.

The Food and Drug Administration has classified a recall of eggs sold at Costco caused by potential salmonella contamination as the highest risk level for infection. The voluntary recall last month was of 10,

The Food and Drug Administration (FDA) has issued a new warning about thousands of recalled eggs sold at Costco (COST) stores due to potential contamination with salmonella, a bacterium that can cause serious infections. The recall has been elevated to the FDA’s highest risk level.

In November, Costco recalled nearly 260,000 eggs sold under the Kirkland Signature brand in 25 stores nationwide. The eggs landed on shelves in Alabama, North Carolina, Georgia, South Carolina and Tennessee starting Nov. 22, according to the company.

While we don’t have specific details about new test results or reports of illness in the case of Costco’s egg recall, the FDA considers several factors when deciding whether to escalate a ...

The FDA has classified its recall of eggs sold under Costco's Kirkland brand as a Class I recall, a designation reserved for instances of the highest potential health risk — including death.

Hundreds of thousands of eggs sold at Costcos that were part of a recall issued last month have a "reasonable" likelihood that consumption may cause serious health problems or death, due to being ...

The antiviral drug nirmatrelvir-ritonavir (Paxlovid) was linked to a lower risk of hospitalization within 30 days and major adverse cardiovascular events (MACEs) and death at 1 year in adults with COVID-19 and chronic kidney disease (CKD) or kidney failure, finds a study this week in Open Forum Infectious Diseases.